BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency

Behdad Afzali(National Institutes of Health), Arian Laurence(University College London Hospitals NHS Foundation Trust), Nichola Cooper(Imperial College London), Joshua McElwee(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carl O'Brien(Imperial College London), Rahul Roychoudhuri(University of Cambridge), Norman R. Watts(Protein Express (United States)), Firas Sadiyah(Babraham Institute), Majid Kazemian(Purdue University West Lafayette), Alejandro V. Villarino(University of Pennsylvania), Timothy J. Aitman(Institute of Genetics and Cancer), Hong‐Wei Sun(Yale University), Dalia Kasperavičiūtė(University of Leeds), Michael Mueller(Genomics England), Warren Strober(Office of Extramural Research), Juha Grönholm(National Institutes of Health), Ivan J. Fuss(National Institutes of Health), Jana Vandrovcová(Texas Tech University), Joshua D. Kaufman(National Institutes of Health), Michelle A. Linterman(Babraham Institute), Ahmed N. Hegazy(Humboldt-Universität zu Berlin), Olena Kamenyeva(National Institutes of Health), John J. O’Shea(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Julia Keith(St. Jude Children's Research Hospital), Kim Montgomery-Recht(Leidos (United States)), Paul T. Wingfield(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Peter Kelleher(St. James's Hospital), Anwar A. Sayed(Taibah University), Holm H. Uhlig(University of Oxford), Michael J. Lenardo(National Institutes of Health), Ine Vanderleyden(Babraham Institute), Nicholas P. Restifo(Lyell Immunopharma (United States)), Ira Palmer(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Yu Zhang(Kunming University of Science and Technology), Jason D. Hughes(University of California, Irvine), Ahmad Khoder(Imperial College London), Fred P. Davis(National Institutes of Health)
Nature Immunology
May 22, 2017
Cited by 158


Related Papers